Latest Breaking News On - Olema pharmaceuticals company profile - Page 1 : comparemela.com

HC Wainwright Boosts Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $28 00

HC Wainwright Boosts Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $28 00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Cyrus harmonAnalyst recommendations for olema pharmaceuticalsOlema pharmaceuticals company profileOlema pharmaceuticals trading downVanguard group incNews ratings for olema pharmaceuticals dailyOlema pharmaceuticalsVictory capital management incChina universal asset management coOlema pharmaceuticals incGoldman sachs groupSecurities exchange commissionHedge funds weigh in on olema pharmaceuticalsFree reportOne financialPharmaceuticals trading down

HC Wainwright Increases Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $28 00

HC Wainwright Increases Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $28 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Cyrus harmonAnalyst recommendations for olema pharmaceuticalsNews ratings for olema pharmaceuticals dailyOlema pharmaceuticals company profileOlema pharmaceuticals incOlema pharmaceuticalsSecurities exchange commissionVivo capitalInstitutional investors weigh in on olema pharmaceuticalsDimensional fund advisorsVanguard group incOlema pharmaceuticals trading downGoldman sachs groupPolar capital holdings plcFree reportOne financial

Cyrus Harmon Sells 5,000 Shares of Olema Pharmaceuticals, Inc (NASDAQ:OLMA) Stock

Cyrus Harmon Sells 5,000 Shares of Olema Pharmaceuticals, Inc (NASDAQ:OLMA) Stock
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Cyrus harmonOlema pharmaceuticals company profileOlema pharmaceuticals incOlema pharmaceuticals stockSecurities exchange commissionGoldman sachs groupQuarter for olema pharmaceuticalsVictory capital management incVanguard group incNews ratings for olema pharmaceuticals dailyOlema pharmaceuticalsChina universal asset management coHedge funds weigh in on olema pharmaceuticalsGet free reportDirector cyrus harmonExchange commission

Olema Pharmaceuticals (NASDAQ:OLMA) Coverage Initiated at The Goldman Sachs Group

The Goldman Sachs Group began coverage on shares of Olema Pharmaceuticals (NASDAQ:OLMA – Free Report) in a research report released on Tuesday morning, MarketBeat reports. The firm issued a buy rating and a $24.00 target price on the stock. Other equities analysts have also recently issued reports about the stock. Citigroup started coverage on shares […]

Cyrus harmonAnalyst recommendations for olema pharmaceuticalsRoyal bankNews ratings for olema pharmaceuticals dailyVirtu financialBalyasny asset managementOlema pharmaceuticalsGoldman sachs groupOlema pharmaceuticals incOlema pharmaceuticals company profileCitigroup incOlema pharmaceuticals stock performanceFree reportOne financialGet free reportDirector cyrus harmon

Olema Pharmaceuticals (NASDAQ:OLMA) Shares Down 8%

Olema Pharmaceuticals (NASDAQ:OLMA) Shares Down 8%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Cyrus harmonGroup plcSecurities exchange commissionPerceptive advisorsHedge funds weigh in on olema pharmaceuticalsNews ratings for olema pharmaceuticals dailyVanguard group incOlema pharmaceuticals company profileInsider transactions at olema pharmaceuticalsBarclays plcOlema pharmaceuticals incOlema pharmaceuticals stock downOlema pharmaceuticalsGet free reportOne financialPharmaceuticals stock down